GSK Payments To Physicians Dropped 33% In 2015; Most Firms Saw Boost
This article was originally published in The Pink Sheet Daily
Executive Summary
Under CMS' Open Payments program, medical product manufacturers reported $7.52bn in payments and ownership and investment interests to physicians and teaching hospitals, up from $6.49bn in 2014.
You may also be interested in...
GSK Returns To Paid External Experts For Physician Communications
Policy update reverses approach announced in 2013 on the basis that physicians prefer peer-to-peer communications with global expert practitioners, firm explains.
AbbVie Hikes Doc Payments By 135%, Merck By 86% As BMS, J&J Cut Spending
Under CMS' Open Payments program, medical product manufacturers reported $8.1bn in payments and ownership and investment interests to physicians and teaching hospitals in 2016, a 1% increase from the previous year.
How To Deter Pharma Conflict Of Interests: Have FDA, CMS Grade Cost-Effectiveness
JAMA editorial suggests ways to reduce conflicts of interest in industry marketing; study shows restricting pharmaceutical detailing at academic medical centers led to 1.67% mean absolute reduction in market share of detailed drugs.